Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a single arm study to evaluate the safety and biodistribution of 177Lu-labeled
anti-ED-B mAbs SPECT imaging in patients with ED-B positive solid tumors.